As evidence continues to evolve, ensuring appropriate access to immunoglobulin (IG) therapy for patients with secondary immunodeficiency (SID) requires collaboration across the healthcare community.
On Friday, August 7, from 9:00–10:30 a.m. ET, the Plasma Protein Therapeutics Association (PPTA) will host Beyond Labels:Ensuring Access to IG Therapy for Secondary Immunodeficiency, a virtual educational webinar designed to bring together diverse perspectives on one of today's important clinical topics.
Explore the Current Landscape
Secondary immunodeficiency, including secondary hypogammaglobulinemia, is an acquired antibody deficiency characterized by low immunoglobulin levels that can leave patients vulnerable to serious infections and other complications. As research advances and clinical understanding grows, continued dialogue is essential to supporting informed,patient-centered care.
During this webinar, attendees will explore:
- Patient experiences living with secondary immunodeficiency
- The latest clinical evidence surrounding IG therapy
- Regulatory perspectives, including insights from the European Medicines Agency (EMA)
- Considerations for supporting responsible, patient-centered care pathways
Hear from Distinguished Speakers
The program features an accomplished panel of experts representing patient advocacy, clinical practice, regulatory science, and the plasma community:
- Dr. James Knowles, Vice President, Global Regulatory Policy & Scientific Affairs, PPTA
- Caroline Voltz-Girolt, Scientific Lead, Oncology and Hematology Office, European Medicines Agency (EMA)
- Charlene Grabowski, Patient and Board Member, Immune Deficiency Foundation (IDF)
- Dr. Stephan Grupp, Section Chief, Cellular Therapy and Transplant, Children's Hospital of Philadelphia (CHOP)
Together, these speakers will examine the evolving evidence surrounding IG therapy while sharing insights from their unique areas of expertise.
Join the Discussion
Whether you are a healthcare professional, researcher,regulator, patient advocate, or member of the plasma community, this webinar offers an opportunity to engage with leading experts and contribute to an important discussion on improving care for patients with secondary immunodeficiency.
Reserve your place today and join us on Friday, August 7,from 9:00–10:30 a.m. ET.